Upregulated ERBB2/HER2 expression could contribute to the formation of ERBB1×ERBB2 heterodimers and thereby potentiate the ability of ERBB1 ligands in the MM TME, such as EGF and AR to promote the survival, proliferation, and dissemination of MM cells. The gene discussed is EGF; the disease is Miyoshi myopathy.